Dengue is a viral disease, commonly transmitted by a mosquito
called Aedes mosquito. It is a common disease in some parts of the world- parts
of Asia and America where the disease is endemic. In the rest of the world the disease most
often is brought in by travellers (70 to 80%) who visit these endemic areas.
About 100 million people get infected by dengue virus every year, so it is
important that we know more about dengue and develop methods to prevent it.
There is no vaccine or prophylactic drug or medicine available to prevent it.
The Aedes mosquito is a funny guy: he prefers to bite and
drink human blood during the day time and hide and rest in dark areas. The
female mosquito whose average life span is 8 to 14 days lays eggs in damp
places that can remain viable for months.
What causes dengue?
Dengue is caused by the dengue virus which is a RNA virus
belonging to the flavivirus genus. A person gets the virus when he is bitten by
the dengue virus carrying mosquito. Once the virus enters the body the person
may manifest with signs and symptoms of the disease which the WHO classifies as
dengue fever and severe dengue fever.
How does the World
Health Organization classify dengue?
The WHO classifies Dengue as dengue fever and severe dengue
fever.
Dengue fever
Acute febrile illness, live in or travel to endemic region,
with two or more of the following:
Nausea and/or vomiting
Headache and/or retro-orbital pain and back pain
Aches and pains
Rash
Tourniquet test positive
Leukopenia
Any warning signs (abdominal pain, persistent vomiting, fluid
accumulation, mucosal bleeding, lethargy, liver enlargement, increase in
hematocrit, falling platelet count with laboratory confirmation)
Severe Dengue Including Dengue Shock Syndrome
Severe capillary permeability and plasma leakage leading to
dengue shock syndrome
Fluid accumulation and respiratory distress
Severe bleeding
Severe organ involvement (liver, CNS, heart, kidneys, and
others)
What are the signs and symptoms of a patient suffering from
dengue?
In its uncomplicated course dengue fever manifest with fever
that may have associated with rashes, aches and pains. Sore throat, coryza,
cough, anorexia, nausea, vomiting, diarrhoea, headache, back pain, myalgia,
arthralgia, and conjunctivitis also may occur.
It usually subsides over period of time with supportive treatment.
However in contrast, in severe dengue fever the walls of our blood vessels
become damaged and unable to properly function. As a result our plasma leaks
out and the blood pressure may rapidly come down- ending in shock stage called
Dengue shock syndrome. Platelet cells that are needed for normal blood clotting
mechanism also can be abnormal or decrease to dangerous levels so that bleed
can easily occur in these patients. The capillary leakage can end up in lung
edema- pulmonary edema, pleural effusion and fluid in our peritoneal cavity- ascites.
Bleeding tendencies can result in skin bleeding- petechiae, mucosal bleeding,
peptic ulcer bleeds, menorrhagia and others. In severe cases intracerebral
(brain) and pulmonary (lung) bleeding can also occur. FDP or Fibrin degradation
products have not been found to be elevated to a degree consistent with classic
disseminated intravascular coagulation (DIC). Some patients may also develop
encephalopathy, pneumonia, and liver dysfunction.
In mild grade of dengue the virus or viral load can be
tackled by our immune system. However in the severe grades of dengue the
increasing virus numbers outdo our immune system (by enhanced infection of monocytes in the
presence of pre-existing anti dengue antibodies at sub neutralizing levels
thereby leading to antibody-dependent immune enhancement) and therefore
presents with severe problems affecting all the body systems slowly.
What are the diseases that may be confused with dengue fever?
(Differential diagnosis)
A number of diseases can be confused with dengue and this
will depend on the region where the patient resides, at what stage the patient
presents to the doctor and also the season it occurs: measles, rubella, enterovirus, influenza,
scrub and murine typhus, septicemia, other viral hemorrhagic fevers (e.g.,
Ebola, Lassa fever), chikungunya, West Nile fever, o’nyong-nyong fever,
malaria, typhoid, leptospirosis, hepatitis A, rickettsiosis, Hanta virus infection,
and Rift Valley fever.
How do we confirm that the patient has dengue infection?
Once the diagnosis of dengue- like disease is thought of
after a through history taking and clinical examination, one must confirm the
diagnosis. Laboratory confirmation is by
the following means:
1) Serologic
confirmation in acute dengue infection -demonstration of specific
immunoglobulin IgM and IgG antibodies against dengue in the serum of patients
2) RT-PCR - Dengue virus RNA also can be amplified by reverse
transcriptase nested polymerase chain reaction (RT-PCR) from serum
3) Viral isolation-culturing the patient's serum with Aedes
albopictus C6/36 cell monolayers and confirming the virus infection of these
cells by immunofluorescent assay using a flavivirus-specific monoclonal
antibody.
How is dengue infection treated?
Patients may present with dengue fever or severe dengue
complicated by shock. Careful clinical assessment with added laboratory
investigations will show grade of dengue infection. There are no specific drugs for dengue so
uncomplicated dengue fever will need good supportive care.
In severe dengue the plasma leak and the clotting
abnormalities are the main problems that need to be tackled. Hypotension and
shock must be treated by judicious fluid resuscitation. The blood volume must
be brought back to normal otherwise the shock will progress to organ failure
and death. The patient's mental status, pulse, temperature, respiratory rate,
blood pressure, central venous pressure, oxygen saturation and urine output
must be measured frequently and checked. Regular hematocrit evaluation will
show if any hemoconcentration is present. The blood volume restoration may need
isotonic crystalloid solutions, plasma or colloid solutions like starch,
dextran and others as deemed by the physician.
(For professionals treating dengue- In patients with dengue
shock, studies have suggested that ringer lactate solution should be started at
a rate of 15 to 20 mL/kg over 1 hour. The patient should be monitored (by various
parameters mentioned before) as then the rate can be reduced to 10 mL/kg/h for
2 hours. As his condition improves it may be reduced to 7.5 ml/kg/ hr. for 2 hrs.
then 5 mL/kg/h for 4 hours, then 2 to 3 mL/kg/h for 24 to 36 hours. If the
clinical condition stabilizes then the fluids can be stopped after this period.
After the first hour of resuscitation colloid solutions or plasma expanders (6%
dextran 70 or 6% starch solution) should be added as needed by the physician if
ringer's by itself is unable to tackle the circulatory collapse. The plasma
leak takes time to settle down and that usually happens by the 7th day.
Children and those below one year as well as those with cardiac or renal diseases will need special care since they are unable to
withstand fluid disturbance or blood volume changes as adults.)
The presence of co morbid conditions like cardiac diseases
and lung diseases will play a great role in the recovery of the patient. Each body
system like the lung and the heart will have to be observed and supported
depending on their performances. For e.g.
Heart- may need inotropic support if it fails to pump well
Lung – may need artificial ventilation support
Fluid collections in lung and peritoneal cavities may need
drainage
Electrolyte imbalances – need to be corrected
Metabolic abnormalities – need corrections
Nutritional support- needed
Bleeding abnormalities will need good evaluation and
corrections depending on the severity. Blood transfusion, platelet concentrates
and fresh frozen plasma may be needed as deemed by the physician treating the
case and not as routine. Steroids are not usually recommended in the treatment
of dengue fever.
How can we avoid getting dengue illness?
Dengue fever is now considered the most important
mosquito-borne viral disease in the world with increasing occurrences in Asia,
Pacific Islands, Caribbean, South America and Africa. Within India in places
like Kerala the weather conditions and water logging helps the mosquito to
breed well, thereby increasing the number of mosquito borne diseases.
Trying to reduce dengue can be done by the following ways:
1) Mosquito
control- mosquitoes can be controlled by killing them. This can be achieved by
pyrethrin knock-down sprays or organophosphate sprays delivered in micro
droplets.
2) Prevent breeding
of mosquitoes- unwanted containers should be discarded, buried or filled with
sand, as water collecting in them provides good breeding grounds. Water
potholes and unwanted water collecting sites should be filled in or destroyed.
3) Killing the
mosquito larvae- Larvae killing small fish or crustaceans called Mesocyclops
can provide control of mosquito larvae.
4) There are
efforts being made to develop a dengue vaccine
5) Research is
being made to develop genetically modified mosquitoes to prevent the breeding
of aedes mosquito
6) Research is
being done to produce antiviral therapies against the dengue virus
7) Avoid mosquito
bites by wearing protective clothing and appropriate repellents
8) Cover all entry
areas into the house by mosquito nets : this will prevent the mosquitoes from passing in
9) Use electric
bats to swat the mosquito that have entered the house and are likely to bite
you while sleeping or resting
10) Travelers who
have returned from endemic areas or those with symptoms and signs mimicking
dengue illness should be observed or even quarantined till cleared of the
illness,
(This original article by Dr Alexander+ is written and compiled in 'public interest’
to create public awareness about Dengue fever and not meant to replace
physician evaluation and treatment++)
Additional resources
www.cdc.gov/dengue
No comments:
Post a Comment